|1.||van de Wetering, M D: 3 articles (01/2007 - 01/2003)|
|2.||van Woensel, J B M: 3 articles (01/2007 - 01/2003)|
|3.||Kingsmore, David: 2 articles (01/2015 - 01/2015)|
|4.||Aitken, Emma: 2 articles (01/2015 - 01/2015)|
|5.||Honour, Patrick: 1 article (01/2015)|
|6.||Chandramohan, Mohan: 1 article (01/2015)|
|7.||Geddes, Colin: 1 article (01/2015)|
|8.||Kasthuri, Ram: 1 article (01/2015)|
|9.||Thomson, Pete: 1 article (01/2015)|
|10.||Johnson, Natalie: 1 article (01/2015)|
04/01/2013 - "Our study demonstrates that, when a dialysis center is moved to a prefabricated temporary building, the likelihood of tCVC infections increases within the initial months and returns back to the previous levels after a period of adaptation."
04/01/2013 - "The aim of our study was to assess the incidence of tCVC infections in a container building. "
01/01/2015 - "Patients who had early infection within 90 days of TCVC insertion were less likely to develop CVS (5.9% vs. 22.8%, p<0.001). "
07/01/2013 - "The project offers a positive cost-benefit balance through a decrease in costs of hospitalisation for tCVC-related infections and other life.threatening conditions related to the use of tCVCs an important goal for any spending review."
07/01/2013 - "In our hospital, tCVC infection occurs 2.4 times in 1000 days during CVC use. "
01/01/2007 - "Depending on the baseline TCVC infection rate it is justified to flush the catheter with a combination of an antibiotic and heparin, if the catheter related infection-rate is high."
01/01/2003 - "Depending on the baseline TCVC infection rate it is justified to administer antibiotics prior to the TCVC insertion or to flush the catheter with a combination of an antibiotic and heparin, if the catheter-related infection rate is high."
01/01/2007 - "To determine the efficacy of administering antibiotics prior to insertion of a TCVC with or without vancomycin/heparin flush technique in the first 45 days after insertion of the catheter to prevent Gram-positive catheter-related infections in oncology patients. "
01/01/2003 - "To determine the efficacy of administering antibiotics prior to insertion of a TCVC with or without vancomycin/heparin flush technique in the first 45 days after insertion of the catheter to prevent Gram-positive catheter-related infections in oncology patients. "
05/01/2005 - "Five trials studied flushing of the TCVC with a vancomycin/heparin solution compared to heparin flushing only. "
01/01/2007 - "Flushing the TCVC with antibiotics and heparin proved to be beneficial (OR = 0.43, 95% CI 0.21 to 0.87). "
01/01/2003 - "Flushing the TCVC with antibiotics and heparin proved to be beneficial (OR = 0.35, 95% CI 0.16 -to 0.77). "
05/01/2005 - "Flushing the TCVC with a vancomycin/heparin solution reduced the incidence of Gram-positive infections."
01/01/2007 - "Four reported on vancomycin/teicoplanin prior to insertion of the TCVC compared to placebo, and five trials reported on antibiotic flushing combined with heparin, compared to heparin flushing only. "
01/01/2009 - "The 3-year actual survival from January 1, 2003 to January 1, 2006 was significantly higher in Group 1 than in Group 2 (80.6% vs. 26.1%; P<0.0001) confirming the higher comorbidity of the patients in Group 2. Patients dialyzing through a TCVC (compared with an AVF) have a significantly higher risk of access-related bacteremia, irrespective of comorbidity."
01/01/2009 - "The incidences of bacteremia in Groups 1 and 2 were, respectively, 0.31 and 0.44 episodes per 1000 patient days while dialyzing through an AVF (P=0.77), and 2.21 and 2.27 per 1000 days while dialyzing through a TCVC (P=0.91). "
10/01/2008 - "Prevention, using strategies to reduce the prevalence of bacteremia, including limiting the use of TCVC, should be an overriding aim."
01/01/2009 - "The incidence of bacteremia is higher in patients dialyzing through a tunneled central venous catheter (TCVC) compared with an arteriovenous fistula (AVF). "
09/01/1990 - "We conclude that the use of an H-V flush solution in immunocompromised patients with TCVC can decrease the frequency of bacteremia attributed to luminal colonization with vancomycin-susceptible bacteria."
01/01/1997 - "Necroses of the proximal tubules were found after TCVC, PCBC and 1,2-DCVC administration in male, but not in female rats. "
06/01/2007 - "exhibited acute tubular necrosis at 2 and 24 h after treatment, and they had elevated blood urea nitrogen levels at 24 h, whereas TCVC was a much less potent nephrotoxicant than TCVCS. "
|1.||Anti-Bacterial Agents (Antibiotics)
|5.||Citric Acid (Citrate)
|9.||cyclo(Arg-Pro) (CI 4)